Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tianlu Huang

CDK7 Inhibitor THZ1 Inhibits McL1 Synthesis and Drives Cholangiocarcinoma Apoptosis in Combination With BCL2/BCL-XL Inhibitor ABT-263

Cell Death and Disease

Molecular Neuroscience

English

Related publications

BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function

English

THZ1 Targeting CDK7 Suppresses STAT Transcriptional Activity and Sensitizes T-Cell Lymphomas to BCL2 Inhibitors

Nature Communications

English

ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells

English

Expression of Apoptosis Inhibitor Protein McL1 Linked to Neuroprotection in CNS Neurons

Cell Death and Differentiation

Cell Biology

Molecular Biology

2004

English

Metabolic Changes Associated With Metformin Potentiates Anti-BCL-2 Inhibitor, Abt-199, and Cdk9 Inhibitor, Bay-1143572 and Reduces Viability of Lymphoma Cells

Hematological Oncology

English

BCL2/MDM2 Inhibitor Combo Effective in AML

Cancer Discovery

Oncology

2019

English

OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor

Journal of Thoracic Oncology

English

Histone Deacetylase Inhibitor Downregulation of BCL-Xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma

American Journal of Respiratory Cell and Molecular Biology

Respiratory Medicine

Pulmonary

Clinical Biochemistry

Cell Biology

Molecular Biology

2001

English

High Glucose Inhibits Apoptosis Induced by Serum Deprivation in Vascular Smooth Muscle Cells via Upregulation of BCL-2 and BCL-Xl

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tianlu Huang

CDK7 Inhibitor THZ1 Inhibits McL1 Synthesis and Drives Cholangiocarcinoma Apoptosis in Combination With BCL2/BCL-XL Inhibitor ABT-263

Related publications

BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function

THZ1 Targeting CDK7 Suppresses STAT Transcriptional Activity and Sensitizes T-Cell Lymphomas to BCL2 Inhibitors

ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells

Expression of Apoptosis Inhibitor Protein McL1 Linked to Neuroprotection in CNS Neurons

Metabolic Changes Associated With Metformin Potentiates Anti-BCL-2 Inhibitor, Abt-199, and Cdk9 Inhibitor, Bay-1143572 and Reduces Viability of Lymphoma Cells

BCL2/MDM2 Inhibitor Combo Effective in AML

OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor

Histone Deacetylase Inhibitor Downregulation of BCL-Xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma

High Glucose Inhibits Apoptosis Induced by Serum Deprivation in Vascular Smooth Muscle Cells via Upregulation of BCL-2 and BCL-Xl